Vivantes - Netzwerk für Gesundheit GmbH

Subtypes of depression and their overlap in a naturalistic inpatient sample of major depressive disorder (2018) Musil R, Seemueller F, Meyer S, Spellmann I, Adli M, Bauer M, Kronmueller KT, et al. Journal article Omalizumab treatment in patients with chronic inducible urticaria: A systematic review of published evidence (2018) Maurer M, Metz M, Brehler R, Hillen U, Jakob T, Mahler V, Pfohler C, et al. Journal article Sustained Need for High-Dose Zinc Supplementation in Children With Acrodermatitis Enteropathica (2018) Hammersen J, Has C, Galiano M, Lindner M, Rossi R, Kohlhase J, Schneider H Journal article Utility of Follow-up Dopamine Transporter SPECT with 123I-FP-CIT in the Diagnostic Workup of Patients with Clinically Uncertain Parkinsonian Syndrome (2017) Apostolova I, Taleb DS, Lipp A, Galazky I, Kupitz D, Lange C, Makowski MR, et al. Journal article Intrauterine Growth Restriction. Guideline of the German Society of Gynecology and Obstetrics (S2k-Level, AWMF Registry No. 015/080, October 2016) (2017) Kehl S, Doetsch J, Hecher K, Schlembach D, Schmitz D, Stepan H, Gembruch U Journal article A randomized phase III study evaluating pegylated liposomal doxorubicin versus capecitabine as first-line therapy for metastatic breast cancer: results of the PELICAN study (2017) Harbeck N, Saupe S, Jaeger E, Schmidt M, Kreienberg R, Mueller L, Otremba BJ, et al. Journal article Is there evidence for a close connection between side of intravesical tumor location and ipsilateral lymphatic spread in lymph node-positive bladder cancer patients at radical cystectomy? Results of the PROMETRICS 2011 database (2017) May M, Protzel C, Vetterlein MW, Gierth M, Noldus J, Karl A, Grimm T, et al. Journal article Current controversies in radiotherapy for breast cancer (2017) Krug D, Baumann R, Budach W, Dunst J, Feyer P, Fietkau R, Haase W, et al. Journal article Neurodevelopmental outcomes of extremely low birthweight infants randomised to different PCO2 targets: the PHELBI follow-up study (2017) Thome UH, Genzel-Boroviczeny O, Bohnhorst B, Schmid M, Fuchs H, Rohde O, Avenarius S, et al. Journal article Assessment of imatinib as first-line treatment of chronic myeloid leukemia: 10-year survival results of the randomized CML study IV and impact of non-CML determinants (2017) Hehlmann R, Lauseker M, Saussele S, Pfirrmann M, Krause S, Kolb HJ, Neubauer A, et al. Journal article